Neuland Laboratories informs about analyst presentation

01 Aug 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Neuland Laboratories has informed that it enclosed the presentation to the Investors/ Analysts on the Financial Results of the Company for the quarter ended June 30, 2024. The presentation is also being uploaded on the website of the Company at www.neulandlabs.com.

The above information is a part of company’s filings submitted to BSE.




Neuland Laboratories Share Price

13611.80 443.95 (3.37%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×